Imprimis Pharmaceuticals Inc. (NASDAQ:IMMY)’s share price shot up 2.9% during trading on Wednesday . The company traded as high as $4.41 and last traded at $4.22, with a volume of 65,629 shares trading hands. The stock had previously closed at $4.10.

Separately, Zacks Investment Research upgraded Imprimis Pharmaceuticals from a “sell” rating to a “hold” rating in a research note on Wednesday, June 1st.

The company’s market capitalization is $55.75 million. The company’s 50-day moving average price is $3.86 and its 200 day moving average price is $3.93.

Imprimis Pharmaceuticals (NASDAQ:IMMY) last issued its quarterly earnings data on Monday, August 15th. The specialty pharmaceutical company reported ($0.35) earnings per share (EPS) for the quarter. The company had revenue of $4.90 million for the quarter, compared to analysts’ expectations of $4.53 million. Analysts predict that Imprimis Pharmaceuticals Inc. will post ($0.94) EPS for the current year.

Imprimis Pharmaceuticals, Inc (Imprimis) is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.